Zobrazeno 1 - 10
of 15
pro vyhledávání: '"K. L. Furie"'
Autor:
Victor Llombart, Thorleif Etgen, Dolors Giralt, Alejandro Bustamante, Carolin Knauer, Jagdish C. Sharma, K. L. Furie, George Giannakoulas, Teresa García-Berrocoso, Wu Zhixin, Tetsu Watanabe, Francisco Purroy, Albert Antolin-Fontes, Ana Catarina Fonseca, Kensaku Shibazaki, Joan Montaner, Manuel Rodríguez-Yáñez, Estevo Santamarina, Naohisa Hosomi, Scott Reza Jafarian Kerman, J. Castillo, Natalia S. Rost, Murat Biteker
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
instname
Background and Purpose— Determining the underlying cause of stroke is important to optimize secondary prevention treatment. Increased blood levels of natriuretic peptides (B-type natriuretic peptide/N-terminal pro-BNP [BNP/NT-proBNP]) have been rep
Autor:
Jonathan Rosand, A. G. Sorensen, Mark Vangel, Hakan Ay, Natalia S. Rost, K. L. Furie, A. Bayrlee, Ethem Murat Arsava
Publikováno v:
Neurology. 77:55-61
To determine whether the extent of leukoaraiosis, a composite marker of baseline brain integrity, differed between patients with TIA with diffusion-weighted imaging (DWI) evidence of infarction (transient symptoms with infarction [TSI]) and patients
Autor:
Michael H. Lev, R.A. Levy, David M. Greer, M. Ebril, Aneesh B. Singhal, É.C. de Camargo, Fabricio O Lima, R. Gilberto Gonzalez, Wade S. Smith, K. L. Furie, Gisele Sampaio Silva, Walter J. Koroshetz, Stuart R. Pomerantz, Hakan Ay
Publikováno v:
American Journal of Neuroradiology. 31:817-821
BACKGROUND AND PURPOSE: Concerns have recently grown regarding the safety of iodinated contrast agents used for CTA and CTP imaging. We tested whether the incidence of AN, defined by a ≥25% increase in the post−contrast scan creatinine level, was
Autor:
W N, Kernan, C M, Viscoli, D, Demarco, B, Mendes, K, Shrauger, J L, Schindler, J C, McVeety, A, Sicklick, D, Moalli, P, Greco, D M, Bravata, S, Eisen, L, Resor, K, Sena, D, Story, L M, Brass, K L, Furie, L, Gutmann, E, Hinnau, M, Gorman, A M, Lovejoy, S E, Inzucchi, L H, Young, R I, Horwitz, R, Cote
Publikováno v:
Neurology. 72:1345-1351
The randomized clinical trial is the preferred scientific strategy for measuring the effectiveness and safety of new therapies for stroke patients. Unfortunately, many recent trials in stroke have been hampered by slow patient accrual.1,2 Trials that
Autor:
Jonathan Rosand, Matthew Traylor, Sudha Seshadri, Veikko Salomaa, Robert Clarke, Anita L. DeStefano, Rodney J. Scott, Steve Bevan, Braxton D. Mitchell, Alun Evans, Philippe Amouyel, Myriam Fornage, Hugh S. Markus, Olli Saarela, Peter Wagner, Dylan Hodgkiss, Angela M. Carter, Giorgio B. Boncoraglio, Catherine Sudlow, K. L. Furie, Will Longstreth, Nicole Soranzo, Peter M. Rothwell, Jean Ferrières, John Attia, Bruce M. Psaty, Martin Dichgans, Christopher Levi, M. Arfan Ikram, Jarmo Virtamo, Gudmar Thorleifsson, Frances M K Williams, Pankaj Sharma, Martin Farrall, Kari Kuulasmaa, Per-Gunnar Wiklund, Elizabeth G. Holliday, James F. Meschia, Anna Helgadottir, Unnur Thorsteinsdottir, Michael A. Nalls, Peter J. Grant, Marco M Ferrario, Dominique Arveiler, Tim D. Spector, Andreas Gschwendtner, Eugenio Parati, Mari A. Kaunisto, Gabriela L. Surdulescu, Joshua C. Bis, Solveig Gretarsdottir, Kaisa Silander, Kari Stefansson, Thomas H. Mosely, Albert Hofman, Pirro G. Hysi, Yu-Ching Cheng, Aarno Palotie
Publikováno v:
Annals of Neurology; Vol 73
Annals of Neurology
Williams, F M K, Carter, A M, Hysi, P G, Surdulescu, G, Hodgkiss, D, Soranzo, N, Traylor, M, Bevan, S, Dichgans, M, Rothwell, P M W, Sudlow, C, Farrall, M, Silander, K, Kaunisto, M, Wagner, P, Saarela, O, Kuulasmaa, K, Virtamo, J, Salomaa, V, Amouyel, P, Arveiler, D, Ferrieres, J, Wiklund, P, Arfan Ikram, M, Hofman, A, Boncoraglio, G B, Parati, E A, Helgadottir, A, Gretarsdottir, S, Thorsteinsdottir, U, Thorleifsson, G, Stefansson, K, Seshadri, S, Destefano, A, Gschwendtner, A, Psaty, B, Longstreth, W, Mitchell, B D, Cheng, Y, Clarke, R, Ferrario, M, Bis, J C, Levi, C, Attia, J, Holliday, E G, Scott, R J, Fornage, M, Sharma, P, Furie, K L, Rosand, J, Nalls, M, Meschia, J, Mosely, T H, Evans, A, Palotie, A, Markus, H S, Grant, P J & Spector, T D 2013, ' Ischemic stroke is associated with the ABO locus: the EuroCLOT study. ', Annals of Neurology, vol. 73, no. 1, pp. 16-31 . https://doi.org/10.1002/ana.23838
Annals of Neurology, 73(1), 16-31. John Wiley & Sons Inc.
Annals of Neurology
Williams, F M K, Carter, A M, Hysi, P G, Surdulescu, G, Hodgkiss, D, Soranzo, N, Traylor, M, Bevan, S, Dichgans, M, Rothwell, P M W, Sudlow, C, Farrall, M, Silander, K, Kaunisto, M, Wagner, P, Saarela, O, Kuulasmaa, K, Virtamo, J, Salomaa, V, Amouyel, P, Arveiler, D, Ferrieres, J, Wiklund, P, Arfan Ikram, M, Hofman, A, Boncoraglio, G B, Parati, E A, Helgadottir, A, Gretarsdottir, S, Thorsteinsdottir, U, Thorleifsson, G, Stefansson, K, Seshadri, S, Destefano, A, Gschwendtner, A, Psaty, B, Longstreth, W, Mitchell, B D, Cheng, Y, Clarke, R, Ferrario, M, Bis, J C, Levi, C, Attia, J, Holliday, E G, Scott, R J, Fornage, M, Sharma, P, Furie, K L, Rosand, J, Nalls, M, Meschia, J, Mosely, T H, Evans, A, Palotie, A, Markus, H S, Grant, P J & Spector, T D 2013, ' Ischemic stroke is associated with the ABO locus: the EuroCLOT study. ', Annals of Neurology, vol. 73, no. 1, pp. 16-31 . https://doi.org/10.1002/ana.23838
Annals of Neurology, 73(1), 16-31. John Wiley & Sons Inc.
OBJECTIVE: End-stage coagulation and the structure/function of fibrin are implicated in the pathogenesis of ischemic stroke. We explored whether genetic variants associated with end-stage coagulation in healthy volunteers account for the genetic pred
Autor:
S. Payabvash, L. C. S. Souza, S. Kamalian, Y. Wang, J. Passanese, S. H. Fung, E. F. Halpern, P. W. Schaefer, R. G. Gonzalez, K. L. Furie, M. H. Lev
Publikováno v:
Neurology. 78(23)
Objective: To develop multivariate models for prediction of early motor deficit improvement in acute stroke patients with focal extremity paresis, using admission clinical and imaging data. Methods: Eighty consecutive patients with motor deficit due
Autor:
Lee H. Schwamm, K. L. Furie, Walter J. Koroshetz, A. G. Sorensen, Jonathan Rosand, Thomas Benner, Ethem Murat Arsava, Hakan Ay, Levent Güngör, Mark Vangel
Background: There is currently no instrument to stratify patients presenting with ischemic stroke according to early risk of recurrent stroke. We sought to develop a comprehensive prognostic score to predict 90-day risk of recurrent stroke. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::923817d09f0303d114c4c742fd625311
https://europepmc.org/articles/PMC2809031/
https://europepmc.org/articles/PMC2809031/
Autor:
Walter J. Koroshetz, K. L. Furie, Xiaoying Wang, M. Barron, A. G. Sorensen, M. Zhu, Eng H. Lo, M. Lederer, MingMing Ning, Hang Lee, Patrick J. Kelly
Publikováno v:
Neurology. 66(10)
Background: Matrix metalloproteinase-9 (MMP9) is expressed in acute ischemic stroke and up-regulated by tissue plasminogen activator (tPA) in animal models. The authors investigated plasma MMP9 and its endogenous inhibitor, tissue inhibitor of metall
Publikováno v:
Internal medicine journal. 34(6)
Atrial fibrillation (AF), an important and treatable cause of ischaemic stroke, can occur as a sustained or a paroxysmal arrhythmia. Continuous cardiac rhythm monitoring (Holter monitoring) is often performed in stroke patients to identify paroxysmal
Autor:
E.H. Picard, Patrick J. Kelly, Vivian E. Shih, K. L. Furie, M. Barron, Joerg Kistler, Roseann Mandell
Publikováno v:
Neurology. 60(2)
Background: Although hyperhomocyst(e)inemia (Hyper-Hcy) may predispose to atherosclerosis and venous thrombosis, the mechanisms of stroke associated with Hyper-Hcy are not defined. Methods: Clinical and biochemical phenotypes and genetic features of